title: Cryptic rearrangement involving MLL and AF10 occurring in utero.
authors.forename: L K
authors.initials: LK
authors.lastname: Jones
authors.forename: M J
authors.initials: MJ
authors.lastname: Neat
authors.forename: F W
authors.initials: FW
authors.lastname: van Delft
authors.forename: M P
authors.initials: MP
authors.lastname: Mitchell
authors.forename: M
authors.initials: M
authors.lastname: Adamaki
authors.forename: S J
authors.initials: SJ
authors.lastname: Stoneham
authors.forename: N
authors.initials: N
authors.lastname: Patel
authors.forename: V
authors.initials: V
authors.lastname: Saha
mesh_terms: D001483:Base Sequence; D004268:DNA-Binding Proteins / Q000235:genetics*; D005260:Female; D005315:Fetal Diseases; D015321:Gene Rearrangement; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D007223:Infant; D007948:Leukemia, Monocytic, Acute / Q000175:diagnosis / Q000235:genetics; D008297:Male; D051788:Myeloid-Lymphoid Leukemia Protein; D011247:Pregnancy; D011519:Proto-Oncogenes; D012074:Remission Induction; D014157:Transcription Factors / Q000235:genetics*
chemical_list: D004268:DNA-Binding Proteins; C497422:KMT2A protein, human; C092513:MLLT10 protein, human; D014157:Transcription Factors; D051788:Myeloid-Lymphoid Leukemia Protein; D011495:Histone-Lysine N-Methyltransferase